1.
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: Results of a phase IIb dose-ranging...
by Ballantyne, Christie M., MD
The American heart journal, 2012, Vol.163 (3), p.515-521.e3

2.
Safety and Tolerability of Dalcetrapib
by Stein, Evan A., MD, PhD
The American journal of cardiology, 2009, Vol.104 (1), p.82-91

3.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2
